- Home
- / Anatara Lifesciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Anatara Lifesciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-04
Market Capitalization
$10.8 M
2024-10-04
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.0K | 663.0K | ||||||
| Gross profit | 1.3M | 1.5M | 790.0K | 1.1M | 487.0K | 1.2M | 644.0K | 969.0K |
| Gross profit margin, % | 22416.7% | 232.4% | ||||||
| Operating expense total | 5.1M | 4.5M | 4.2M | 3.1M | 3.0M | 3.3M | 2.1M | 2.9M |
| Depreciation and amortization | 21.0K | 23.0K | 16.0K | 6.0K | 25.0K | 25.0K | 2.0K | 1.0K |
| EBITDA | (3.8M) | (3.0M) | (3.4M) | (2.0M) | (2.5M) | (2.0M) | (1.5M) | (2.0M) |
| EBITDA margin, % | -62800.0% | -450.7% | ||||||
| EBIT | (3.8M) | (3.0M) | (3.4M) | (2.0M) | (2.5M) | (2.0M) | (1.5M) | (2.0M) |
| EBIT margin, % | -63150.0% | -454.1% | ||||||
| Interest income | 220.0K | 143.0K | 52.0K | 9.0K | 6.0K | 18.0K | 8.0K | 9.0K |
| Interest expense | 34.0K | 3.0K | 2.0K | 7.0K | ||||
| Pre tax profit | (3.6M) | (2.9M) | (3.4M) | (2.0M) | (2.5M) | (2.0M) | (1.5M) | (2.0M) |
| Net Income | (3.6M) | (2.9M) | (3.4M) | (2.0M) | (2.5M) | (2.0M) | (1.5M) | (2.0M) |